Skip to main content

Align Technology guidance

  • ALGN · Nasdaq
  • Medical devices
  • Health Care Supplies
  • S&P 500
$165.98−1.39%Close 16 Nov 2026 · Market value $11.58B

In its results release of 28 Oct 2026 (Q3 FY2026), Align Technology gave 7 forecasts in figures, among them revenue of $1.00B to $1.02B for Q4 FY2026. Over the last two years, results landed above the company's own last range 12 of 28 times, within it 9 and below it 7.

Read from the company's earnings releases and outlook updates of the last two years. Each forecast is shown with the sentence or table row it was read from; what a release does not state in figures is not shown.

Latest guidance given with Q3 FY2026 results, 28 Oct 2026

MeasurePeriodGuidanceAs stated
RevenueQ4 FY2026$1.00B to $1.02BWe expect Q4’26 worldwide revenues to be in the range of $1,000M to $1,020M.
Gross margin · AdjustedQ4 FY2026About 72%We expect Q4’26 non-GAAP Gross Margin to be approximately 72.0%.
Operating margin · GAAPQ4 FY2026About 20%We expect Q4’26 GAAP Operating Margin to be approximately 20.0%.
Operating margin · AdjustedQ4 FY2026About 26%We expect Q4’26 non-GAAP Operating Margin to be approximately 26.0%.
RevenueFY2026$4.11B to $4.13BWe expect 2026 worldwide revenue to be approximately in the range of $4,110M to $4,130M.
Operating margin, change · GAAPFY2026About +270 bpWe expect 2026 GAAP Operating Margin to be approximately 16.2%, up approximately 2.7 points year-over-year.
Operating margin · AdjustedFY2026About 23.7%We expect 2026 non-GAAP Operating Margin to be approximately 23.7%, a 100-basis point improvement year-over-year consistent with our previous guidance.

Source: the company's earnings release.

Guidance against results above 12 · within 9 · below 7

The last range given before each period closed, how it moved between releases, and the figure then filed. A measure the company defines itself, or one not comparable with the filed figure, has no verdict.

MeasurePeriodLast guidanceRevisionsDeliveredResult
Operating margin, change · AdjustedFY2027About +100 bpGiven once—To come
Revenue growthFY2026+3% to +4%Unchanged—To come
RevenueFY2026$4.11B to $4.13BGiven once—To come
Gross margin · GAAPFY202670.2% to 70.5%Given once—To come
Gross margin · AdjustedFY202671.7%Given once—To come
Operating margin · GAAPFY2026About 15.1% to 15.6%Lowered once—To come
Operating margin · AdjustedFY2026About 23.7%Unchanged—To come
Operating margin, change · GAAPFY2026About +270 bpGiven once—To come
RevenueQ4 FY2026$1.00B to $1.02BGiven once—To come
Gross margin · AdjustedQ4 FY2026About 72%Given once—To come
Operating margin · GAAPQ4 FY2026About 20%Given once—To come
Operating margin · AdjustedQ4 FY2026About 26%Given once—To come
Gross margin · GAAPQ3 FY202667.5% to 68.5%Given once68.73%Above the range
Gross margin · AdjustedQ3 FY202671%Given once70.4%Below the range
Operating margin · GAAPQ3 FY202613.5% to 15%Given once16.67%Above the range
Operating margin · AdjustedQ3 FY2026About 24%Given once24.4%Within the range
RevenueQ2 FY2026$1.04B to $1.06BGiven once$1.06BWithin the range
Revenue growthQ2 FY2026About +3% to +5%Given once+4.32%Within the range
Operating margin · AdjustedQ2 FY202621.5%Given once22.9%Above the range
RevenueQ1 FY2026$1.01B to $1.03BGiven once$1.04BAbove the range
Revenue growthQ1 FY2026+3% to +5%Given once+6.21%Above the range
Operating margin · GAAPQ1 FY202612.4% to 12.8%Given once13.65%Above the range
Operating margin · AdjustedQ1 FY202619.5%Given once21.5%Above the range
Gross margin · GAAPFY202567% to 68%Given once67.19%Within the range

ALGN in the terminal

Guidance said on earnings calls, every revision charted, and guidance set against the analysts' consensus.